The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells

被引:18
作者
Buckle, AM [1 ]
Mottram, R
Pierce, A
Lucas, GS
Russell, N
Miyan, JA
Whetton, AD
机构
[1] Univ Manchester, Dept Biomol Sci, Leukaemia Res Fund, Manchester M60 1QD, Lancs, England
[2] Manchester Royal Infirm, Dept Clin Haematol, Manchester M13 9WL, Lancs, England
[3] City Hosp Nottingham, Dept Haematol, Nottingham, England
关键词
D O I
10.1007/BF03401826
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Chronic Myeloid Leukaemia (CML) is characterised by the chromosomal translocation resulting in expression of the Bcr-Abl protein tyrosine kinase (PTK) in early stem cells and their progeny. However the precise nature of Bcr-Abl effects in primitive CML stem cells remains a matter of active debate. Materials and Methods: Extremely primitive Bcr-Abl fusion positive cells were purified from patients with CML using multiparameter flow cytometric analysis of CD34, Thy, and lineage marker (Lin) expression, plus rhodamine-123 (Rh-123) brightness. Progenitor cells of increasing maturity were examined for cycling status by flow cytometry and their proliferative status directly correlated with cell phenotype. The activation status of a key transcription factor. signal transducers and activators of transcription (STAT-5), was also analyzed by immunocytochemistry. Results: The most primitive stem cells currently defined (CD34+Lin-Thy+Rh-1231o) were present as a lower proportion of the stem cell compartment (CD34+Lin-) of CML patients at presentation than of normal individuals (2.3% +/- 0.4 compared with 5.1% +/- 0.6 respectively). Conversely there was a significantly higher proportion of the more mature cells (CD34+Lin-Thy-Rh-123 hi) in CML patients than in normal individuals (79.3 +/- 1.8 compared with 70.9 +/- 3.3). No primitive subpopulation of CML CD34+Lin- cells was cycling to a significantly greater degree than cells from normal donors, in fact, late progenitor cells (CD34+Lin+) were cycling significantly less in CML samples than normal samples. STAT5, however, was observed to be activated in CML cells. Conclusions: We conclude that no subpopulation of CML stem cells displays significantly increased cell cycling. Thus, increased cycling cannot be a direct consequence of Bcr-Abl PTK acquisition in highly enriched stem cells from patients with CML. Ln vivo CML need not be considered a disease of unbridled stem cell proliferation, but a subtle defect in the balance between self renewal and maturation.
引用
收藏
页码:892 / 902
页数:11
相关论文
共 51 条
[1]   ISOLATION OF A CANDIDATE HUMAN HEMATOPOIETIC STEM-CELL POPULATION [J].
BAUM, CM ;
WEISSMAN, IL ;
TSUKAMOTO, AS ;
BUCKLE, AM ;
PEAULT, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2804-2808
[2]  
BERTONCELLO I, 1985, EXP HEMATOL, V13, P999
[3]  
CARLESSO N, 1994, ONCOGENE, V9, P149
[4]   INTEGRATION OF MOLECULAR AND BIOLOGICAL ABNORMALITIES IN QUEST FOR SELECTIVE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA (CML) [J].
CLARKSON, B ;
STRIFE, A ;
PEREZ, A ;
LAMBEK, C ;
WISNIEWSKI, D .
LEUKEMIA & LYMPHOMA, 1993, 11 :81-100
[5]   TRANSFORMATION OF AN INTERLEUKIN-3-DEPENDENT HEMATOPOIETIC-CELL LINE BY THE CHRONIC MYELOGENOUS LEUKEMIA-SPECIFIC P210BER/ABL PROTEIN [J].
DALEY, GQ ;
BALTIMORE, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) :9312-9316
[6]   INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME [J].
DALEY, GQ ;
VANETTEN, RA ;
BALTIMORE, D .
SCIENCE, 1990, 247 (4944) :824-830
[7]  
DALEY GQ, 1991, ADV CANCER RES, V57, P151
[8]   Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia [J].
Dewald, GW ;
Wyatt, WA ;
Juneau, AL ;
Carlson, RO ;
Zinsmeister, AR ;
Jalal, SM ;
Spurbeck, JL ;
Silver, RT .
BLOOD, 1998, 91 (09) :3357-3365
[9]  
Eaves A C, 1998, Stem Cells, V16 Suppl 1, P77
[10]   Defective regulation of leukemic hematopoiesis in chronic myeloid leukemia [J].
Eaves, C ;
Cashman, J ;
Eaves, A .
LEUKEMIA RESEARCH, 1998, 22 (12) :1085-1096